| Revisiting neoadjuvant therapy in non-small-cell lung cancer SPL Saw, BH Ong, KLM Chua, A Takano, DSW Tan The Lancet Oncology 22 (11), e501-e516, 2021 | 143 | 2021 |
| Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients S Saw, HY Lee, QS Ng European Journal of Cancer 81, 237-239, 2017 | 115 | 2017 |
| MET alterations in NSCLC—current perspectives and future challenges J Remon, LEL Hendriks, G Mountzios, R García-Campelo, SPL Saw, ... Journal of Thoracic Oncology 18 (4), 419-435, 2023 | 76 | 2023 |
| Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor–positive non–small cell lung cancer SPL Saw, S Zhou, J Chen, G Lai, MK Ang, K Chua, R Kanesvaran, QS Ng, ... JAMA Network Open 4 (11), e2131892-e2131892, 2021 | 39 | 2021 |
| Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice S Saw, J Lim, SH Lim, M Wong, C Lim, YS Yap Breast Cancer Research and Treatment 177, 197-206, 2019 | 16 | 2019 |
| PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer SPL Saw, WP Ng, S Zhou, GGY Lai, AC Tan, MK Ang, WT Lim, ... European Journal of Cancer 178, 139-149, 2023 | 15 | 2023 |
| A randomized phase 2 trial of nivolumab versus nivolumab-ipilimumab combination in EGFR-mutant NSCLC GGY Lai, JC Yeo, A Jain, S Zhou, M Pang, JJS Alvarez, NL Sim, AC Tan, ... JTO Clinical and Research Reports 3 (12), 100416, 2022 | 15 | 2022 |
| Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges J Remon, SPL Saw, F Cortiula, PK Singh, J Menis, G Mountzios, ... Journal of Thoracic Oncology 19 (2), 199-215, 2024 | 14 | 2024 |
| Adjuvant immunotherapy in patients with early-stage non-small cell lung cancer and future directions SPL Saw, MK Ang, DSW Tan Current treatment options in oncology 23 (12), 1721-1731, 2022 | 13 | 2022 |
| Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small … AC Tan, SPL Saw, J Chen, GGY Lai, HN Oo, A Takano, DPX Lau, ... JCO Precision Oncology 6, e2200278, 2022 | 12 | 2022 |
| Practical barriers to implementation of thyroid cancer guidelines in the asia-pacific region SP Yang, LS Ying, S Saw, RM Tuttle, K Venkataraman, C Su-Ynn Endocrine Practice 21 (11), 1255-1268, 2015 | 11 | 2015 |
| Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage … AC Tan, GGY Lai, SPL Saw, KLM Chua, A Takano, BH Ong, TPT Koh, ... Cancer 130 (10), 1758-1765, 2024 | 9 | 2024 |
| New Treatment Options for Patients With Oncogene-Addicted Non–Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors SPL Saw, X Le, LEL Hendriks, J Remon American Society of Clinical Oncology Educational Book 44 (3), e432516, 2024 | 7 | 2024 |
| Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small … AC Tan, SP Saw, GG Lai, KL Chua, A Takano, BH Ong, TP Koh, A Jain, ... Cancer Research 82 (12_Supplement), 5114-5114, 2022 | 7 | 2022 |
| MA07. 06 circulating tumor DNA for monitoring minimal residual disease and early detection of recurrence in early stage lung cancer A Tan, G Lai, S Saw, K Chua, A Takano, B Ong, T Koh, A Jain, W Tan, ... Journal of Thoracic Oncology 16 (10), S907, 2021 | 6 | 2021 |
| Oncogene-Driven Non–Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations CY Huang, N Jiang, M Shen, GG Lai, AC Tan, A Jain, SP Saw, MK Ang, ... Cancer Research 84 (12), 2009-2020, 2024 | 3 | 2024 |
| Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC SPL Saw, YF Low, GGY Lai, LL Chan, WKY Wong, G Tsui, OH Chen, ... Lung Cancer 193, 107856, 2024 | 2 | 2024 |
| Multidisciplinary lung cancer clinic: An emerging model of care SPL Saw, KLM Chua, BH Ong, DWT Lim, GGY Lai, DSW Tan, MK Ang Annals of the Academy of Medicine, Singapore 51 (12), 793-795, 2022 | 2 | 2022 |
| Co-targeting the VEGF axis and immune checkpoints in NSCLC: back to the future SPL Saw, DSW Tan Annals of Oncology 32 (9), 1075-1076, 2021 | 2 | 2021 |
| Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen … SPL Saw, G San Tan, WC Tan, AC Tan, GGY Lai, DWT Lim, ... JTO Clinical and Research Reports 4 (12), 100599, 2023 | 1 | 2023 |
